Tristel plc (AIM:TSTL)

Market Cap	199.34M
Revenue (ttm)	46.46M
Net Income (ttm)	6.64M
Shares Out	47.75M
EPS (ttm)	0.14
PE Ratio	30.19
Forward PE	24.20
Dividend	0.14 (3.40%)
Ex-Dividend Date	Nov 27, 2025

Volume	15,212
Average Volume	90,344
Open	413.20
Previous Close	410.00
Day's Range	410.00 - 420.50
52-Week Range	260.00 - 444.25
Beta	0.23
RSI	68.77
Earnings Date	Feb 24, 2026

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wip...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 267
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: TSTL

Financial Performance

In 2025, Tristel's revenue was 46.46 million, an increase of 10.80% compared to the previous year's 41.93 million. Earnings were 6.64 million, an increase of 2.33%.